ProShares - Ultra Dow30 (DDM)
DDM: Not A Good Time For Leverage
ProShares Ultra Dow30 ETF (DDM) offers 2x daily Dow Jones exposure but is highly volatile and subject to decay, especially in choppy markets. While DDM has delivered robust long-term returns, its deep drawdowns and high volatility make it risky for passive, long-term holding. Current market valuations are stretched, with sentiment in 'Greed' territory and P/E ratios above historical averages, signaling caution for leveraged exposure.
DDM: A Hedging Or Trading Tool, Not A Buy
DDM is designed for 2x daily Dow Jones 30 performance, making it suitable for short-term speculation or hedging, not long-term investing. Leveraged ETFs like DDM can significantly deviate from their daily targets over longer periods, especially in volatile markets, leading to potential losses. The fund uses derivatives, which lose time value over time, further reinforcing that DDM is not appropriate for buy-and-hold strategies.
SOPHiA GENETICS Launches MSK-IMPACT® powered with SOPHiA DDM™ at AMP 2024
Launch of new application enables global access to highly recognized solid tumor profiling assay BOSTON and ROLLE, Switzerland , Nov. 21, 2024 /PRNewswire/ -- SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native healthcare technology leader in data-driven medicine, announced the global launch of MSK-IMPACT® powered with SOPHiA DDM™ today from the Association for Molecular Pathology (AMP) Annual Meeting. This innovative solution provides organizations worldwide with the opportunity to benefit from Memorial Sloan Kettering Cancer Center (MSK)'s best-in-class comprehensive genomic profiling (CGP) application on the SOPHiA DDM™ Platform with high accuracy and efficiency.
DDM: Double Your Industrials Daily
ProShares Ultra Dow30 ETF offers 2x daily leverage on the Dow Jones Industrial Average, ideal for short-term, high-risk tactical moves. The DDM ETF achieves leverage through swaps with major banks, providing exposure to blue-chip stocks like Apple and Goldman Sachs without owning them directly. This ETF is best for bullish investors on the Dow, but its daily resets can cause tracking errors and increased volatility over longer periods.
SOPHiA DDM™ Platform Certified Under IVDR
Regulatory milestone validates the SOPHiA DDM™ Platform as diagnostic tool in select markets BOSTON and ROLLE, Switzerland , Aug. 14, 2024 /PRNewswire/ -- SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native healthcare technology company and a global leader in data-driven medicine, today announced that its SOPHiA DDM™ Platform is now CE marked under the European Union's In Vitro Diagnostic Regulation (IVDR). IVDR certification is a significant regulatory milestone that validates the powerful analytical capabilities of the SOPHiA DDM™ Platform and allows customers throughout the European Union and other markets recognizing this certification to use the SOPHiA DDM™ Platform to support patient diagnostics.
SOPHiA GENETICS Announces L'hôpital Universitaire Avicenne is Live on SOPHiA DDM™
The hospital will use the SOPHiA DDM™ Platform to enhance its testing and research of blood cancers BOSTON and ROLLE, Switzerland , July 29, 2024 /PRNewswire/ -- SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native healthcare technology company and a leader in data-driven medicine, today announced that L'hôpital Universitaire Avicenne is implementing the SOPHiA DDM™ Platform. The hospital, located in Bobigny, France, will use the platform to advance its testing and research of blood-related cancers and disorders.
India-Based Dhiti Omics is Now Live on SOPHiA DDM™
The diagnostics company has implemented the SOPHiA DDM™ Platform to enhance its solid tumor testing BOSTON and ROLLE, Switzerland , July 4, 2024 /PRNewswire/ -- SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native healthcare technology company and a global leader in data-driven medicine, today announced that Dhiti Omics Technologies, a precision molecular diagnostics service provider in India, is live on the SOPHiA DDM™ Platform. The company will use SOPHiA GENETICS' technology to enhance its solid tumor testing capabilities.
SOPHiA GENETICS Announces Kepler Uniklinikum is Live on SOPHiA DDM™ Platform
The Hospital will use SOPHiA DDM™ to enhance its testing and research of blood cancers BOSTON and ROLLE, Switzerland , June 13, 2024 /PRNewswire/ -- SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native healthcare technology company and a leader in data-driven medicine, today announced that Kepler Uniklinikum, Austria's second largest hospital, is live on SOPHiA GENETICS' platform. The hospital will use the SOPHiA DDM™ Platform to advance its next-generation sequencing (NGS) testing and diagnostics of blood-related cancers.
BioReference® Signs On as the First Laboratory to Use MSK-ACCESS® Powered with SOPHiA DDM™
World-class liquid biopsy testing will be made commercially available to BioReference® customers across the country BOSTON and ELMWOOD PARK, N.J. and ROLLE, Switzerland , Nov. 7, 2023 /PRNewswire/ -- SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native software company and a leader in data-driven medicine, today announced that BioReference® Health, LLC, an OPKO Health, Inc. company and full-service laboratory that processes more than 12 million tests annually, will implement SOPHiA GENETICS' technology and add MSK-ACCESS® liquid biopsy to its test suite.
BioReference® Signs On as the First Laboratory to Use MSK-ACCESS® Powered with SOPHiA DDM™
World-class liquid biopsy testing will be made commercially available to BioReference® customers across the country BOSTON and ELMWOOD PARK, N.J., and ROLLE, Switzerland , Nov. 7, 2023 /PRNewswire/ -- SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native software company and a leader in data-driven medicine, today announced that BioReference® Health, LLC, an OPKO Health, Inc. company and full-service laboratory that processes more than 12 million tests annually, will implement SOPHiA GENETICS' technology and add MSK-ACCESS® liquid biopsy to its test suite.
Inflation, Rising Rates, And Rotation
This is a weekly series focused on analyzing the previous week's economic data releases.
Tepid Economic Recovery: The iM-Weekly Unemployment Monitor: Update 3/5/2021
A truer picture of the employment situation is extracted from the Unemployment Insurance Weekly Claims (UIWC) report.
World Markets Update: September 14, 2020
Six of eight indexes on our world watch list posted losses through September 14, 2020. The top performer is China's Shanghai with a gain of 7.50%.
The Endless 'Bull Vs. Bear' And 'Value Vs. Growth' Debate
The two market metrics which I watch closely (outside of S&P 500 earnings) are market breadth and market sentiment.
S&P 500 Weekly Update: The Pause Is Here And The Talk Of A 'Market Crash' Is Everywhere
Global Manufacturing and Services PMIs continue to promote the V recovery theme. The consumer stays resilient as evidenced by the Auto and Housing sectors.
Markit Services PMI: 'Strongest Expansion In Business Activity Since March 2019'
The August US Services Purchasing Managers' Index conducted by Markit came in at 55.0 percent, up 5.0 from the final July estimate of 50.0.
... But Valuations Remain Compelling
The signs of excesses are too much to ignore. Don't pick a top, but reduce downside exposure in equity index products.
DDM Holding AG and DDM Treasury Sweden AB: Financial results January-June 2014
STOCKHOLM--(BUSINESS WIRE)--Regulatory News: DDM Holding AG (Nasdaq OMX First North: DDM), a leading multinational investor and manager of distressed assets, and its subsidiary DDM Treasury Sweden AB (publ) today announced their Q2 2014 interim reports. The complete interim reports are available on the group’s website, www.ddm-group.ch. Commenting on the results, Mr. Gustav Hultgren, CEO of DDM Holding AG, said: "Following the first quarter of 2014 with geopolitical turbulence and pressure on the Russian Ruble, the second quarter 2014 was characterised by two mile stone events. Firstly, preparations for the listing of DDM on Nasdaq OMX First North in Stockholm and secondly, increased portfolio investments. During the second quarter 2014, we reengaged with investments in Russia and also made a first investment in Slovenia. During the first six months of 2014, DDM invested in portfolios to a total amount of EUR 7.1 M." Today, at 10:00 a.m. CET, Gustav Hultgren will comment on development in a conference call with investors, analysts and media. The conference may be followed via webcast on www.ddm-group.ch or by telephone with dial-in numbers: Sweden: +46 8 519 990 30, Switzerland: +41 225 675 542 or United Kingdom: +44 207 660 2077. Participants are advised to register via email to investor@ddm-group.ch. For more information, please visit DDM’s website at www.ddm-group.ch or contact: Anders Antonsson, Investor RelationsMail: a.antonsson@ddm-group.ch | Tel: 46 8 4080 9030 DDM Holding AG (Nasdaq OMX First North: DDM) is a leading multinational investor and manager of distressed assets. Since 2007, the DDM Group has built a successful platform in Eastern Europe, with over 2 million receivables in nominal value over EUR 1.4 billion. DDM Treasury Sweden AB (publ) (NGM: DDM1) is a subsidiary wholly owned by DDM Holding AG. Pareto Securities is DDM Holding AG’s Certified Adviser. This information was brought to you by Cision http://news.cision.com